•  Nasdaq

  •  OTC BB


    BIOLASE (BIOL) Expects Revenue to Exceed $18M for Q4 2012

    January 07 Jan 2013 | 10:50




    http://pennyomega.com/img/biol.jpg BIOL, BIOLASE, Inc.

    ** BIOL reported that, based on a preliminary review of its financial performance for the fourth quarter ended December 31, 2012, BIOL expects to exceed its previous guidance and report net revenue in excess of $18 million.

    BIOL‘s patented WaterLase technology combines its proprietary 2,780nm YSGG laser energy, air, and water that all emanate from its patented hand piece to symbiotically excite water molecules from within both the spray and the target tissue.


    BIOL is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine.

    More about BIOL at www.biolase.com





    Read Full Disclaimer at http://CRWENews.com/disclaimer

    Tags: , ,



     CRWE Network